Advertisement

ANP/NPRA Inhibits Epithelial-Mesenchymal Transition of Airway by Targeting Smad3 in Asthma

  • Shuyuan Chu
  • Xiufeng Zhang
  • Yabing Sun
  • Yaxi Liang
  • Jingyi Sun
  • Minyan Lu
  • Jianwei Huang
  • Ming Jiang
  • Libing MaEmail author
Article
  • 5 Downloads

Abstract

Atrial natriuretic peptide (ANP) has a protective effect on allergic disorders of airway. It could inhibit transforming growth factor beta 1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) of human airway cells. In this study, we investigated the role and mechanism of ANP in airway EMT with asthma. Asthma model was established with BALB/c mice using ovalbumin. Asthmatic mice were respectively treated with ANP, NPRA antagonist (A71915) or ANP+A71915. The protein expressions of TGF-β1, ANP, epithelial cadherin (E-Cadherin), α-smooth muscle actin (α-SMA), Smad3 and phosphorylated-Smad3 in lung tissues were detected by immunohistochemistry and Western blotting. The mRNA expressions of E-Cadherin, α-SMA, Smad3 in lung tissues were measured using real-time PCR. The levels of TGF-β1, IL-4 and IL-5 in bronchoalveolar lavage fluid, cyclic guanosine monophosphate (cGMP) in lung tissues, and ANP in serum were assessed by ELISA. Compared with controls, mRNA and protein expressions of E-Cadherin were decreased, whereas α-SMA were increased in asthma group, which could be reversed by ANP. cGMP level was higher in ANP group than asthma group, whereas p-Smad3 expression was lower. TGF-β1, IL-4 and IL-5 levels were higher in asthma group than controls, which could be reversed by ANP. The effect of ANP in asthma group could be inhibited by A71915. Therefore, in asthma, ANP/NPRA could inhibit airway EMT by targeting Smad3 via attenuating phosphorylation of Smad3. cGMP signaling may be involved into this process. This may provide a potential of ANP in treatment on refractory asthma with airway remodeling.

Keywords

Atrial natriuretic peptide Asthma Epithelial-mesenchymal transition Smad3 

Notes

Acknowledgements

This work was supported by grants from the National Natural Science Foundation of China (Nos. 81360006, 81560007 and 81760009), the Guangxi Natural Science Foundation (No. 2015GXNSFAA139106), and the Education Department of Hunan Province (No. 16C1404). The funding sources had no involvement into this study.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflict of interest.

References

  1. Chen J, Wang D, Wang F, Shi S, Chen Y, Yang B et al (2017) Exendin-4 inhibits structural remodeling and improves Ca2+ homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway. Peptides 90:69–77CrossRefGoogle Scholar
  2. Chu S, Zhang X, Sun Y, Yu Y, Liang Y, Jiang M et al (2017) Atrial natriuretic peptide: a novel mediator for TGF-β1-induced epithelial-mesenchymal transition in 16HBE-14o and A549 cells. Peptides 90:1–9CrossRefGoogle Scholar
  3. Duechs MJ, Tilp C, Tomsic C, Gantner F, Erb KJ (2014) Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment. PLoS ONE 9(3):e91223CrossRefGoogle Scholar
  4. Ferreira MPA, Ranjan S, Kinnunen S, Correia A, Talman V, Mäkilä E et al (2017) Drug-loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic signaling. Small.  https://doi.org/10.1002/smll.201701276 Google Scholar
  5. Gong K, Xing D, Li P, Hilgers RH, Hage FG, Oparil S et al (2011) cGMP inhibits TGF-beta signaling by sequestering Smad3 with cytosolic beta2-tubulin in pulmonary artery smooth muscle cells. Mol Endocrinol 25(10):1794–1803CrossRefGoogle Scholar
  6. Inserte J, Garcia-Dorado D (2015) The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism. Br J Pharmacol 172(8):1996–2009CrossRefGoogle Scholar
  7. Kumar M, Behera AK, Lockey RF, Vesely DL, Mohapatra SS (2002) Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization. J Allergy Clin Immunol 110(6):879–882CrossRefGoogle Scholar
  8. Li P, Oparil S, Novak L, Cao X, Shi W, Lucas J et al (2007) ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. J Appl Physiol (1985) 102(1):390–398CrossRefGoogle Scholar
  9. Li P, Wang D, Lucas J, Oparil S, Xing D, Cao X et al (2008) Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102(2):185–192CrossRefGoogle Scholar
  10. Livak K, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408CrossRefGoogle Scholar
  11. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2095–2128CrossRefGoogle Scholar
  12. Luna LG (1968) Manual of histologic staining methods of the armed forces institute of pathology, 3rd edn. McGraw-Hill, New York, pp 4–8Google Scholar
  13. Ma L, Xiang X (2011) Atrial natriuretic peptide/natriuretic peptide receptor A (ANP/NPRA) signaling pathway: a potential therapeutic target for allergic asthma. Med Hypotheses 77(5):832–833CrossRefGoogle Scholar
  14. Ma L, Zeng J, Mo B, Wang C, Sun Y, Zhang M et al (2015) ANP/NPRA signaling preferentially mediates Th2 responses in favor of pathological processes during the course of acute allergic asthma. Int J Clin Exp Med 8(4):5121–5128Google Scholar
  15. Mcmillan SJ, Lloyd CM (2004) Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 34:497–507CrossRefGoogle Scholar
  16. Mizuguchi M, Myo S, Fujimura M (2000) Bronchoprotective effects of atrial natriuretic peptide against propranolol-induced bronchoconstriction after allergic reaction in guinea pigs. Clin Exp Allergy 30(3):439–444CrossRefGoogle Scholar
  17. Moubarak M, Magaud C, Saliba Y, Chatelier A, Bois P, Faivre JF et al (2015) Effects of atrial natriuretic peptide on rat ventricular fibroblasts during differentiation into myofibroblasts. Physiol Res 64(4):495–503Google Scholar
  18. van Buul AR, Taube C (2015) Treatment of severe asthma: entering the era of targeted therapy. Expert Opin Biol Ther 15(12):1713–1725CrossRefGoogle Scholar
  19. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2163–2196CrossRefGoogle Scholar
  20. Yu Y, Zeng J, Sun Y, Wei J, Huang J, Ma L (2016) Serum levels of ANP signaling in different degree of allergic asthmatics and its role in the pathogenesis of allergic asthma. Zhong Nan Da Xue Xue Bao Yi Xue Ban 41(7):684–690Google Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Respiratory and Critical Care MedicineThe Affiliated Hospital of Guilin Medical UniversityGuilinChina
  2. 2.Institute of Respiratory DiseasesGuilin Medical UniversityGuilinChina
  3. 3.Key Laboratory of Respiratory Diseases of Colleges and Universities Affiliated Education Department of Guangxi Zhuang Autonomous RegionGuilinChina
  4. 4.Department of Respiratory MedicineThe Second Affiliated Hospital of Hainan Medical UniversityHaikouChina

Personalised recommendations